Suppr超能文献

蛋白酶激活受体3(PAR3)的表达在人红白血病(HEL)细胞中通过诱导巨核细胞表型而上调。

Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.

作者信息

Cupit Lisa D, Schmidt Valentina A, Gnatenko Dmitri V, Bahou Wadie F

机构信息

Department of Medicine, State University of New York at Stony Brook, NY 11794-8151, USA.

出版信息

Exp Hematol. 2004 Oct;32(10):991-9. doi: 10.1016/j.exphem.2004.07.005.

Abstract

OBJECTIVE

Two major protease-activated receptors (PARs), PAR1 and PAR4, are involved in the activation of human platelets by thrombin. A third, PAR3, is preferentially expressed by tissues of hematopoietic origin and megakaryocytes. Although PAR3 is also a thrombin substrate, its low-level expression on human platelets suggests a function distinct from that of PAR1, the major receptor involved in thrombin-mediated platelet activation. We studied the expression of PARs during megakaryocyte differentiation of human erythroleukemia (HEL) cells in order to determine the role of PAR3 in megakaryocytopoiesis.

METHODS

HEL cells exposed to phorbol 12-myristate 13-acetate (PMA) to induce megakaryocyte differentiation were examined by light microscopy and flow cytometry (DNA ploidy, surface expression of PAR1, PAR3, GPIIb-IIIa). Northern blot, RT-PCR, and quantitative RT-PCR were used to evaluate the expression of PARs 1, 3, and 4 mRNA. HEL cells were also exposed to thrombin and thrombopoietin (TPO).

RESULTS

In baseline studies, unstimulated HEL cells were found to express comparable levels of PAR1 and PAR3 by Northern blot. Minimal expression of PAR4 was detected by RT-PCR, but not by Northern analysis. Exposure to PMA, but not thrombin or TPO, resulted in megakaryocytic differentiation as evident by increased cell size and nuclear complexity, increased ploidy, and enhanced expression of GPIIb-IIIa, a specific marker of megakaryocytes/platelets. PMA-stimulated HEL cells showed enhanced PAR3 cell-surface expression (approximately threefold increase by day 2) by flow cytometry. In contrast, there was no change in cell-surface PAR1 expression. Northern blot analysis (approximately 10-fold) and quantitative RT-PCR (approximately threefold) confirmed the upregulation of PAR3 mRNA expression (by 24 hours) in cells exposed to PMA. This did not occur with exposure to TPO.

CONCLUSION

These data demonstrate increased expression of PAR3 mRNA and protein in HEL cells undergoing megakaryocytic maturation following PMA exposure, suggesting a developmental role for PAR3. Furthermore, regulation of PAR3 expression appears to be specifically coupled to the protein kinase C system, but independent of the Ras/Raf/MAP kinase pathway.

摘要

目的

两种主要的蛋白酶激活受体(PARs),即PAR1和PAR4,参与凝血酶对人血小板的激活。第三种受体PAR3优先在造血起源组织和巨核细胞中表达。尽管PAR3也是凝血酶的底物,但其在人血小板上的低水平表达表明其功能不同于PAR1,PAR1是参与凝血酶介导的血小板激活的主要受体。我们研究了人红白血病(HEL)细胞巨核细胞分化过程中PARs的表达,以确定PAR3在巨核细胞生成中的作用。

方法

通过光学显微镜和流式细胞术(DNA倍性、PAR1、PAR3、糖蛋白IIb-IIIa的表面表达)检测暴露于佛波酯12-肉豆蔻酸酯13-乙酸酯(PMA)以诱导巨核细胞分化的HEL细胞。采用Northern印迹、逆转录聚合酶链反应(RT-PCR)和定量RT-PCR评估PAR1、PAR3和PAR4 mRNA的表达。HEL细胞也暴露于凝血酶和血小板生成素(TPO)。

结果

在基础研究中,通过Northern印迹发现未刺激的HEL细胞表达相当水平的PAR1和PAR3。通过RT-PCR检测到PAR4有最低限度的表达,但Northern分析未检测到。暴露于PMA而非凝血酶或TPO会导致巨核细胞分化,表现为细胞大小和核复杂性增加、倍性增加以及巨核细胞/血小板特异性标志物糖蛋白IIb-IIIa的表达增强。流式细胞术显示,PMA刺激的HEL细胞PAR3细胞表面表达增强(到第2天增加约三倍)。相比之下,细胞表面PAR1表达没有变化。Northern印迹分析(约10倍)和定量RT-PCR(约三倍)证实,暴露于PMA的细胞中PAR3 mRNA表达(24小时内)上调。暴露于TPO时未出现这种情况。

结论

这些数据表明,暴露于PMA后,经历巨核细胞成熟的HEL细胞中PAR3 mRNA和蛋白表达增加,提示PAR3具有发育作用。此外,PAR3表达的调节似乎与蛋白激酶C系统特异性相关,但独立于Ras/Raf/丝裂原活化蛋白激酶途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验